Europe (WHO region) vs Monaco: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Europe (WHO region)
91.0%
in 2025
Monaco
99.0%
in 2025
Europe (WHO region) rank
3rd
Monaco rank
1st
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Europe (WHO region)
- Monaco
How they compare
Monaco currently reports 99.0% against 91.0% in Europe (WHO region), a difference of 8.0%.
That makes Monaco's figure about 1.1 times Europe (WHO region)'s.
Across all 26 years both countries report, Monaco has been ahead every year.
Europe (WHO region) ranks 3rd and Monaco ranks 1st of 11 groups.
Monaco has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.3% | 99.0% | 4.7% | Monaco |
| 2010s | 93.5% | 99.0% | 5.5% | Monaco |
| 2020s | 91.7% | 99.0% | 7.3% | Monaco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Europe (WHO region) or Monaco?
- Monaco, at 99.0% against 91.0% in Europe (WHO region) as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Europe (WHO region) and Monaco?
- 8.0%, with Monaco ahead.
- How many years of comparable data are there for Europe (WHO region) and Monaco?
- 26 years are reported by both, from 2000 to 2025.
- How do Europe (WHO region) and Monaco rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Europe (WHO region) ranks 3rd and Monaco ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.